Effects of different progestins on prostaglandin biosynthesis in human endometrial explants
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study investigated how various progestins impact prostaglandin production in human endometrial tissue explants.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model.Study designHuman endometrial explants obtained by aspiration curettage and human endometrial YHES cells were stimulated with interleukin-1β (IL-1β) and exposed to CMA, DNG, DRSP or dexamethasone (DEX; YHES cells). Cellular messenger RNA (mRNA) levels of cyclooxygenase-2 (COX-2) were analyzed by reverse-transcription quantitative real-time polymerase chain reaction. Concentrations of prostaglandin F2α (PGF2α) in culture supernatants were measured by enzyme-linked immunosorbent assay.ResultsCMA exerted after IL-1β stimulation a stronger down-regulation of COX-2 mRNA compared to DNG and DRSP in human explants (-55% vs. -40% and 46%, respectively). The effect of CMA on COX-2 mRNA was significantly stronger (p=.025) than that of DNG. Moreover, the effect of CMA was independent from cycle phase or presence of endometriosis. In order to evaluate the impact of the investigated progestins on effector molecules, PGF2α release was determined in supernatants. Again, CMA reduced the PGF2α release significantly by an average of -60% (p<.01). In contrast, no significant reduction was found for DNG and DRSP. In YHES cells, only DEX but not the progestins under study exerted a significant down-regulating effect (-79%, p<.01) on COX-2 mRNA after IL-1β stimulation.ConclusionAmong the tested progestins, CMA displayed the most consistent suppression of prostaglandin biosynthesis in human endometrial explants.ImplicationAmong three tested progestins, chlormadinone acetate had the most consistent suppressive effect on prostaglandins in endometrial explants. These findings support clinical observations about the efficacy of chlormadinone acetate in dysmenorrhea treatment.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms via openalex
- Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine via openalex
- Endocrine Regulation of Menstruation via openalex
- Endometriosis via openalex
- Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea via openalex
- Menstrual physiology: implications for endometrial pathology and beyond via openalex
- Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer via openalex
- Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis via openalex
- doi:10.1093/molehr/gaq094 via openalex
- doi:10.1159/000226601 via openalex
- doi:10.2165/11532910-000000000-00000 via openalex
- doi:10.1210/endo-106-5-1599 via openalex
- doi:10.1016/s1472-6483(10)61759-2 via openalex
- doi:10.1111/j.1471-0528.1965.tb01415.x via openalex
- doi:10.1002/14651858.cd001751.pub3 via openalex
- doi:10.1136/bmj.332.7550.1134 via openalex
- doi:10.2217/whe.10.84 via openalex
- doi:10.1016/j.fertnstert.2012.06.010 via openalex
- doi:10.1002/14651858.cd002120.pub3 via openalex
- doi:10.1093/molehr/gal034 via openalex
- doi:10.2165/11586720-000000000-00000 via openalex
- doi:10.1196/annals.1429.007 via openalex
- doi:10.1016/s0010-7824(02)00536-x via openalex
- doi:10.1080/13625180500434897 via openalex
- doi:10.1007/bf02134006 via openalex
- doi:10.1016/0022-4731(86)90068-3 via openalex
- doi:10.1080/13625180600772741 via openalex
- doi:10.1002/14651858.cd002120.pub2 via openalex
- doi:10.1007/s11095-007-9291-7 via openalex
- doi:10.1093/molehr/gaq095 via openalex
- doi:10.1210/jc.2010-2489 via openalex
- doi:10.1016/j.contraception.2009.09.014 via openalex
- doi:10.1016/j.jsbmb.2013.08.001 via openalex
- doi:10.1016/j.contraception.2007.03.014 via openalex
- doi:10.1016/j.lfs.2006.01.018 via openalex
- doi:10.1016/j.mce.2010.08.006 via openalex
- doi:10.1023/a:1020072325818 via openalex
- doi:10.1080/13625180500434889 via openalex
- doi:10.1016/j.contraception.2007.07.002 via openalex
- doi:10.1016/j.fertnstert.2004.06.057 via openalex
- doi:10.1016/s0731-7085(99)00244-7 via openalex
Cited by (3)
- Is primary dysmenorrhea a precursor of future endometriosis development? 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Comparison of the Efficacy and Tolerability of Dienogest and Dienogest Plus Ethinylestradiol on Endometriosis Related-Pain 2019
Source provenance
- europepmc
- last seen: 2026-08-24T06:08:07.662257+00:00
- openalex
- last seen: 2026-05-11T06:17:40.080092+00:00
- pubmed
- last seen: 2026-05-13T22:19:37.156494+00:00
- unpaywall
- last seen: 2026-08-24T06:27:14.670421+00:00
License: CC0
· commercial use OK